Kyowa Kirin Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$126.09 | $130.51 | 14.20% | 11 | $327.97B |
| ROG | Roche Holding | Hold |
16
|
CHF228.80 | CHF307.83 | 19.10% | 9 | CHF185.94B |
| SAN | Sanofi | Outperform |
16
|
88.58€ | 102.80€ | 23.05% | 9 | 112.34€B |
| GSK | GSK | Outperform |
12
|
£17.40 | £17.30 | 14.66% | 12 | £72.36B |
| SGEN | Seattle Genetics Inc | - |
16
|
$228.74 | $225.41 | 0.11% | 1 | $43.15B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.20 | $9.50 | 53.23% | 5 | $2.55B |
| 600267 | Zhejiang Hisun Pharmaceutical | Hold |
11
|
¥7.87 | ¥15.60 | 5.46% | 0 | ¥13.66B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$27.07 | $41.00 | 49.61% | 0 | $1.72B |
| HRTX | Heron Therapeutics | Buy |
7
|
$3.41 | $5.63 | 90.62% | 0 | $442.92M |
| URGN | UroGen Pharma | Outperform |
6
|
$13.61 | $39.00 | 193.90% | 4 | $434.72M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.70 | $200.00 | -100.00% | 1 | $0.53M |